Steroid-induced osteoporosis.
Reid
I R
IR
Department of Medicine, University of Auckland, New Zealand. i.reid@auckland.ac.nz
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D015519:Bone Density / Q000187:drug effects; D002116:Calcitonin / Q000627:therapeutic use; D002118:Calcium / Q000008:administration & dosage; D004164:Diphosphonates / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy; D005260:Female; D005459:Fluorides / Q000627:therapeutic use; D005598:Fractures, Spontaneous / Q000209:etiology; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D010024:Osteoporosis / Q000139:chemically induced* / Q000188:drug therapy; D011282:Pregnenediones / Q000627:therapeutic use; D012307:Risk Factors; D013997:Time Factors; D014807:Vitamin D / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D004164:Diphosphonates; D005938:Glucocorticoids; D011282:Pregnenediones; D014807:Vitamin D; D002116:Calcitonin; C021988:deflazacort; D005459:Fluorides; D002118:Calcium